Responsive image

Common name


aniline

IUPAC name


aniline

SMILES


Nc1ccccc1

Common name


aniline

IUPAC name


aniline

SMILES


Nc1ccccc1

INCHI


InChI=1S/C6H7N/c7-6-4-2-1-3-5-6/h1-5H,7H2

FORMULA


C6H7N

Responsive image

Common name


aniline

IUPAC name


aniline





Molecular weight


93.126

clogP


1.260

clogS


-1.189

Frequency


0.0247





HBond Acceptor


0

HBond Donor


2

Total Polar
Surface Area


26.02

Number of Rings


1

Rotatable Bond


0

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00751 Oxybuprocaine Responsive image Anesthetics, Local; Ophthalmologicals; Sensory Organs; Dermatologicals; Local Anesthetics; Anesthetics for Topical Use; Antipruritics, Incl. Antihistamines, Anesthetics, Etc.; Used to temporarily numb the front surface of the eye so that the eye pressure can be measured or a foreign body removed.
FDBD00770 Anileridine Responsive image Anesthetics; Nervous System; Anesthetics, General; Opioid Anesthetics; For treatment and management of pain (systemic) and for use as an anesthesia adjunct.
FDBD00787 Tipranavir Responsive image Anti-HIV Agents; Protease Inhibitors; Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; For combination antiretroviral treatment of HIV-1 infected adult patients with evidence of viral replication, who are highly treatment-experienced or have HIV-1 strains resistant to multiple protease inhibitors.
FDBD00818 Bromfenac Responsive image Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Ophthalmologicals; Sensory Organs; For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
FDBD00869 Sulfamethoxazole Responsive image Anti-Infective Agents; Sulfonamides; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Sulfonamides and Trimethoprim; Intermediate-Acting Sulfonamides; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP3A4 Inhibitors; For the treatment bacterial infections causing bronchitis, prostatitis and urinary tract infections.
FDBD00888 Procainamide Responsive image Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ia; CYP2D6 Inducers; CYP2D6 Inducers (strong); For the treatment of life-threatening ventricular arrhythmias.
FDBD00894 Melphalan Responsive image Antineoplastic Agents; Immunosuppressive Agents; Antineoplastic Agents, Alkylating; Alkylating Agents; Myeloablative Agonists; Antineoplastic and Immunomodulating Agents; Nitrogen Mustard Analogues; For the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary. Has also been used alone or as part of various chemotherapeutic regimens as an adjunct to surgery in the treatment of breast cancer, alone or in combination regimens for palliative treatment of locally recurrent or unresectable in-transit metastatic melanoma of the extremities, as well as for the treatment of amyloidosis with prednisone.
FDBD00936 Benzocaine Responsive image Anesthetics, Local; Anesthetics; Respiratory System; Throat Preparations; Dermatologicals; Nervous System; Cardiovascular System; Anesthetics, General; Local Anesthetics; Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use; Vasoprotectives; Anesthetics for Topical Use; Antipruritics, Incl. Antihistamines, Anesthetics, Etc.; Esters of Aminobenzoic Acid; For general use as a lubricant and topical anesthetic on esophagus, larynx, mouth, nasal cavity, rectum, respiratory tract or trachea, urinary tract, vagina. It is also used to suppress gag reflex.
FDBD00993 Sulfoxone Responsive image Anti-Infective Agents; Sulfonamides; For the treatment of leprosy and dermatitis herpetiformis.
FDBD01004 Trimetrexate Responsive image Antifungal Agents; Antiprotozoal Agents; Folic Acid Antagonists; Antimetabolites, Antineoplastic; Antibiotics; Antiparasitic Products, Insecticides and Repellents; For use, with concurrent leucovorin administration (leucovorin protection), as an alternative therapy for the treatment of moderate-to-severe .
72 , 8
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
3fui_ligand_1_3.mol2 3fui 1 -6.80 c1ccc(cc1)N 7
4l02_ligand_1_2.mol2 4l02 1 -6.77 Nc1ccccc1 7
4o2a_ligand_frag_2.mol2 4o2a 1 -6.76 c1(ccccc1)N 7
3ftw_ligand_1_0.mol2 3ftw 1 -6.75 c1ccccc1N 7
2vba_ligand_1_1.mol2 2vba 1 -6.74 c1(ccccc1)N 7
3ftv_ligand_1_0.mol2 3ftv 1 -6.74 c1ccccc1N 7
3ftz_ligand_frag_0.mol2 3ftz 1 -6.74 Nc1ccccc1 7
1cx9_ligand_frag_0.mol2 1cx9 1 -6.72 c1cc(ccc1)N 7
2hz0_ligand_1_6.mol2 2hz0 1 -6.72 c1ccccc1N 7
4p72_ligand_1_3.mol2 4p72 1 -6.71 Nc1ccccc1 7
542 , 55